Author:
Zhao Xueqi,Li Yingbo,Li Zhenli,Hu Dexiang,Zhang Ruiwen,Li Mengzhen,Liu Yaoyang,Xiu Xiaomeng,Jia Hongwei,Wang Hanxun,Liu Yang,Yang Huali,Cheng Maosheng
Reference43 articles.
1. Alzheimer's disease
2. The U. S. Food and drug administration. FDA's Decision to Approve New Treatment for Alzheimer's Disease [EB/OL]. (2021-07-06), https://www.fda.gov/drugs/our-perspective/fdas-decision-approve-new-treatment-alzheimers-disease.
3. World Alzheimer report 2018 (https://www.alzint.org/u/WorldAlzheimerReport2018.pdf).
4. The β-amyloid hypothesis in Alzheimer's disease: seeing is believing;Kung;ACS Med. Chem. Lett.,2012
5. Near-infrared fluorescent probes as imaging and theranostic modalities for amyloid-beta and tau aggregates in Alzheimer’s disease;Rai;J. Med. Chem.,2022